Manifold MarketsSans KYCDonnées de résolution vérifiéesAssez bien calibréPrévision communautaire actuelleNon 64.1%
Prévisionnistes
184
Type de question
binary
Méthodologie
Play-money forecasting platform
Type de source
Prévision
Données du marché
Mis à jour il y a 6 heures
Obsolète14 mars 26, 20:19 UTC31 déc. 27, 20:12 UTC
Tendances
Marchés Associés
Questions liées pour le contexte, et non une comparaison de contrats équivalents.
Is Rosie the dog's AI-designed mRNA cancer vaccine legitimate?
Manifold MarketsFDA approves skin cancer vaccine by which date?
PolymarketWill FDA approve any mRNA vaccine against melanoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against any strain of influenza before 2028?
Manifold MarketsSkin cancer vaccine BLA submitted by which date?
PolymarketRègles
In 2025, Sydney tech entrepreneur Paul Conyngham used ChatGPT and AI tools to help design a personalised mRNA cancer vaccine for his rescue dog Rosie, a staffy–Shar Pei cross diagnosed with mast cell cancer.
- After conventional chemotherapy slowed but failed to shrink the tumours, Conyngham used AI to help sequence Rosie's tumour DNA, identify mutations, and design an mRNA vaccine.
- The vaccine was manufactured at the UNSW RNA Institute and administered under ethics approval at the University of Queensland.
- Rosie received her first injection in December 2025, followed by a booster in early 2026.
- Results became visible about a month after treatment, with the primary tumour shrinking by approximately 75%, though at least one tumour did not respond.
- This resolves based on my subjective judgment of whether the result appears to be a legitimate, real therapeutic effect — not a fluke, misattribution, or hype cycle.
